The ASHP accredited PGY2 Oncology Pharmacy Residency at KCC is a twelve-month program that provides advanced clinical training and experience in the management of patients with malignant disease. The oncology resident will have the opportunity to collaborate with hematologists / oncologists, fellows, clinical pharmacy specialists, and Wayne State University faculty to build on and gain knowledge in a wide variety of areas. The oncology specialized residency program will be tailored to the needs of the resident based on previous clinical experience.
Interested candidates should possess a Doctor of Pharmacy degree and have completed a PGY1 pharmacy practice residency. The applicant must be licensed or eligible for licensure in the State of Michigan
About Karmanos Cancer Center
The Karmanos Cancer Center (KCC) is the patient care enterprise of the Karmanos Cancer Institute (KCI). The KCI is a National Cancer Institute-designated Comprehensive Cancer Center in association with Wayne State University. The Department of Pharmacy Services at KCC provides services to an inpatient facility licensed for 123 beds as well as a large, dynamic ambulatory clinic and one off-site infusion center.